FLT3 inhibitors: a paradigm for the development of targeted therapeutics for paediatric cancer.

doi:10.1016/j.ejca.2003.08.030

Back to search

Article

FLT3 inhibitors: a paradigm for the development of targeted therapeutics for paediatric cancer.

European journal of cancer (Oxford, England : 1990) - 1 Mar 2004

Brown P, Small D

Abstract excerpt

The area of molecularly-targeted cancer therapeutics is generating tremendous interest and excitement. While clinical investigation of these agents has been largely limited to adults, clinical trials for paediatric cancer patients with many of these agents are now underway. This paper reviews the...

Topics

Adjuvants, Immunologic
Cell Line, Tumor
Child
Forecasting
Gene Expression
Genetic Therapy
Humans
Leukemia
Membrane Proteins
Mutation
Neoplasms

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.